Research findings, strategies target the leading cause of Latino death With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the […]

The process is often imagined as a single, sudden 'aha!' moment. It’s much more like building a massive, intricate structure—a colossal puzzle that represents all medical knowledge. Every time a treatment is approved, a new piece of the puzzle clicks into place. 

UT Health San Antonio’s advanced endoscopy team leads efforts in early detection and prevention Gastrointestinal cancers were previously believed to primarily affect older adults, but over the past two decades, rates of these cancers have increased dramatically in people under age 50. A new report from the Dana-Farber Cancer Institute reveals that colorectal, pancreatic, esophageal […]

UT Health San Antonio’s Advanced Interventional Gastroenterology Program is now offering an advanced, minimally invasive procedure that allows physicians to remove large, early-stage colorectal lesions without the need for traditional surgery.

UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review.

UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.

Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology of the Joe R. and Teresa Lozano Long School of Medicine and co-director of the cryo-EM facility at The University of Texas at San Antonio, has been selected by the Howard Hughes Medical Institute (HHMI) as a Freeman Hrabowski Scholar. The five-year […]

FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues   For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]